Sensus Blog

The future of skin cancer treatment is now. Stay ahead of the curve with our library of informational blogs.

April
27
2026

Basal Cell Carcinoma vs. Squamous Cell Carcinoma: What’s the Difference?

Melanoma and non-melanoma are two primary categories of skin cancer. Each presents different symptoms and treatment options. Within the non-melanoma skin cancer – sometimes referred to as NMSC – category, the two most common types…

November
29
2018

Sensus Healthcare Installs First Groundbreaking SRT-100+ Superficial Radiation Therapy System for Treating Keloid Scars

Dr. Kenrick Spence of Hillcrest Plastic Surgery in Orlando First to Offer System BOCA RATON, Fla., Nov. 29, 2018 — Sensus Healthcare, Inc. (NASDAQ: SRTS), a medical device company specializing in the non-invasive treatment of…

November
29
2018

Sensus Healthcare Installs First Groundbreaking SRT-100+ Superficial Radio Therapy System for Treating Keloid Scars

Dr. Kenrick Spence of Hillcrest Plastic Surgery in Orlando First to Offer System BOCA RATON, Fla., Nov. 29, 2018 — Sensus Healthcare, Inc. (NASDAQ: SRTS), a medical device company specializing in the non-invasive treatment of…

November
05
2018

8th Annual “New Frontiers in Cosmetic Medicine” (NFCM) Symposium

Join Sensus Healthcare at our Superficial Radio Therapy session taking place during the upcoming New Frontiers in Cosmetic Medicine (NFCM) Symposium on Sunday, November 18th. For more information click here, or to register click here.

November
01
2018

Sensus Healthcare Third Quarter Financial Results Feature Revenue Growth of 32%

Shipped 18 systems during the quarter including 15 SRT-100 Vision™ systems Conference call begins at 4:30 p.m. Eastern time today BOCA RATON, Fla., Nov. 1, 2018 — Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device…

Archives
Archives

IN THE NEWS

CEO Joseph Sardano on Coding for Superficial Radiation Therapy